You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors

Article info

Article menu
Immune cell therapies and immune cell engineering
Original research
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors

Authors

  • Chia-Ing Jan Department of Pathology, China Medical University Hospital, Taichung, TaiwanDepartment of Medicine, China Medical University, Taichung, TaiwanTranslational Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Shi-Wei Huang Translational Cell Therapy Center, China Medical University Hospital, Taichung, TaiwanInstitute of New Drug Development, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Peter Canoll Department of Pathology and Cell Biology, Columbia University, New York, New York, USA PubMed articlesGoogle scholar articles
  • Jeffrey N Bruce Department of Neurosurgery, Columbia University, New York, New York, USA PubMed articlesGoogle scholar articles
  • Yu-Chuan Lin Translational Cell Therapy Center, China Medical University Hospital, Taichung, TaiwanDrug Development Center, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Chih-Ming Pan Translational Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Hsin-Man Lu Department of Psychology, Asia University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Shao-Chih Chiu Translational Cell Therapy Center, China Medical University Hospital, Taichung, TaiwanDrug Development Center, China Medical University, Taichung, TaiwanGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Der-Yang Cho Translational Cell Therapy Center, China Medical University Hospital, Taichung, TaiwanDrug Development Center, China Medical University, Taichung, TaiwanGraduate Institute of Biomedical Sciences, China Medical University, Taichung, TaiwanDepartment of Neurosurgery, China Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles

Citation

Jan C, Huang S, Canoll P, et al
Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
Journal for ImmunoTherapy of Cancer 2021;9:e003050. doi: 10.1136/jitc-2021-003050
Online issue publication 
June 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.